We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+12.48%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$20.1B
AUM Growth
+$1.71B
Cap. Flow
-$319M
Cap. Flow %
-1.59%
Top 10 Hldgs %
38.54%
Holding
575
New
91
Increased
134
Reduced
234
Closed
49

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$215M
2
AAPL icon
Apple
AAPL
+$134M
3
MCHP icon
Microchip Technology
MCHP
+$131M
4
TMUS icon
T-Mobile US
TMUS
+$120M
5
CTSH icon
Cognizant
CTSH
+$118M

Sector Composition

Rank Sector Weight
1 Technology 25.01%
2 Communication Services 18.63%
3 Healthcare 14.3%
4 Consumer Discretionary 12.48%
5 Financials 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAX icon
376
Baxter International
BAX
$11.6B
$304K ﹤0.01%
5,869
-11,187
-66% -$550K
STN icon
377
Stantec
STN
$7.69B
$261K ﹤0.01%
+10,070
New +$264K
HRC
378
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$247K ﹤0.01%
+3,500
New +$223K
AYI icon
379
Acuity Brands
AYI
$9.88B
$234K ﹤0.01%
1,145
-7,567
-87% -$1.6M
AVXS
380
DELISTED
AveXis, Inc. Common Stock
AVXS
$228K ﹤0.01%
+3,000
New +$186K
EVR icon
381
Evercore
EVR
$13.1B
$215K ﹤0.01%
+2,762
New +$214K
PPG icon
382
PPG Industries
PPG
$25.9B
$179K ﹤0.01%
1,700
-300
-15% -$30.4K
CRIS icon
383
Curis
CRIS
$9.53M
$167K ﹤0.01%
30
+5
+20% +$27.8K
AXTA icon
384
Axalta
AXTA
$7.01B
$160K ﹤0.01%
4,957
AMTD
385
DELISTED
TD Ameritrade Holding Corp
AMTD
$156K ﹤0.01%
4,014
-86,066
-96% -$3.66M
OXFD
386
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$155K ﹤0.01%
+10,000
New +$143K
DORM icon
387
Dorman Products
DORM
$4.01B
$153K ﹤0.01%
+1,861
New +$138K
CALA
388
DELISTED
Calithera Biosciences, Inc
CALA
$150K ﹤0.01%
+650
New +$112K
SIOX
389
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$149K ﹤0.01%
+1,250
New +$131K
MET icon
390
MetLife
MET
$61B
$143K ﹤0.01%
3,029
-4,825
-61% -$230K
AMBA icon
391
Ambarella
AMBA
$2.99B
$137K ﹤0.01%
+2,500
New +$135K
SGEN
392
DELISTED
Seagen Inc. Common Stock
SGEN
$126K ﹤0.01%
+2,000
New +$125K
WLL
393
DELISTED
Whiting Petroleum Corporation
WLL
$124K ﹤0.01%
44
-1,111
-96% -$3.6M
PGC icon
394
Peapack-Gladstone Financial
PGC
$822M
$122K ﹤0.01%
+4,138
New +$128K
AGIO icon
395
Agios Pharmaceuticals
AGIO
$2.16B
$117K ﹤0.01%
+2,000
New +$95.9K
WAB icon
396
Wabtec
WAB
$51.1B
$114K ﹤0.01%
1,465
-175,664
-99% -$14.5M
DOV icon
397
Dover
DOV
$27.2B
$104K ﹤0.01%
1,609
-1,238
-43% -$78.9K
HPQ icon
398
HP
HPQ
$23.5B
$67K ﹤0.01%
3,730
+703
+23% +$11.4K
VMW
399
DELISTED
VMware, Inc
VMW
$60K ﹤0.01%
655
+85
+15% +$7.48K
BEN icon
400
Franklin Resources
BEN
$16.9B
$58K ﹤0.01%
1,388

Similar funds

Fred Alger Management's Q1 2017 Portfolio in Review

As of Q1 2017, Fred Alger Management held 575 positions worth $20.1B, up 9.3% from $18.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Fred Alger Management's Q1 2017 filing shows 91 new, 134 increased, 234 reduced and 49 closed positions. Its largest new stake was Microchip Technology: 3,702,676 shares worth $137M. The largest sale was Alphabet (Google) Class C, an estimated $387M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Communication Services and Healthcare.

  • Fred Alger Management's largest Q1 2017 buy was Microchip Technology: 3,702,676 shares worth $137M.
  • Fred Alger Management added most to Walt Disney in Q1 2017, an estimated $215M increase.
  • Fred Alger Management's biggest Q1 2017 reduction was Alphabet (Google) Class C, cutting an estimated $387M.
  • Fred Alger Management fully exited Terminix Global Holdings, Inc. in Q1 2017, selling an estimated $59M.
  • Fred Alger Management's ten largest holdings make up 39% of its $20.1B portfolio in Q1 2017.
  • Fred Alger Management opened 91 new positions and closed 49 in Q1 2017.
  • Fred Alger Management's portfolio value rose 9.3% quarter-over-quarter to $20.1B.

Based on Fred Alger Management's 13F filing for Q1 2017, filed 15 May 2017.